Chargement en cours...
Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2
Knowing the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to bind to the angiotensin-converting enzyme 2 (ACE2) receptor and to enter cells via endocytosis paved the way for repositioning of old drugs as potential treatment of COVID-19, the disease caused by SARS-CoV-2 infe...
Enregistré dans:
| Publié dans: | Int J Antimicrob Agents |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7546948/ https://ncbi.nlm.nih.gov/pubmed/33045350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2020.106192 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|